[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2009 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Feb-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Dec-2009 [#4]
Profit Trend
QoQ- 17.93%
YoY- 0.27%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Revenue 1,336,309 1,335,790 1,270,240 1,300,796 1,302,520 1,293,856 1,254,864 4.27%
PBT 64,217 65,516 49,724 81,436 71,930 89,042 80,736 -14.14%
Tax -21,201 -17,862 -12,488 -19,709 -19,116 -22,610 -21,964 -2.32%
NP 43,016 47,654 37,236 61,727 52,814 66,432 58,772 -18.76%
-
NP to SH 43,520 48,108 37,228 60,191 51,038 64,438 58,088 -17.49%
-
Tax Rate 33.01% 27.26% 25.11% 24.20% 26.58% 25.39% 27.20% -
Total Cost 1,293,293 1,288,136 1,233,004 1,239,069 1,249,705 1,227,424 1,196,092 5.34%
-
Net Worth 424,715 417,306 439,675 431,158 407,610 400,063 402,378 3.66%
Dividend
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Div 67,041 100,581 - 39,585 38,514 57,763 - -
Div Payout % 154.05% 209.07% - 65.77% 75.46% 89.64% - -
Equity
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Net Worth 424,715 417,306 439,675 431,158 407,610 400,063 402,378 3.66%
NOSH 106,981 107,001 106,977 106,987 106,984 106,968 107,015 -0.02%
Ratio Analysis
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
NP Margin 3.22% 3.57% 2.93% 4.75% 4.05% 5.13% 4.68% -
ROE 10.25% 11.53% 8.47% 13.96% 12.52% 16.11% 14.44% -
Per Share
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
RPS 1,249.11 1,248.38 1,187.40 1,215.84 1,217.49 1,209.56 1,172.60 4.29%
EPS 40.68 44.96 34.80 56.26 47.71 60.24 54.28 -17.47%
DPS 62.67 94.00 0.00 37.00 36.00 54.00 0.00 -
NAPS 3.97 3.90 4.11 4.03 3.81 3.74 3.76 3.68%
Adjusted Per Share Value based on latest NOSH - 107,001
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
RPS 92.72 92.68 88.13 90.25 90.37 89.77 87.07 4.27%
EPS 3.02 3.34 2.58 4.18 3.54 4.47 4.03 -17.48%
DPS 4.65 6.98 0.00 2.75 2.67 4.01 0.00 -
NAPS 0.2947 0.2895 0.3051 0.2992 0.2828 0.2776 0.2792 3.66%
Price Multiplier on Financial Quarter End Date
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Date 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 -
Price 4.98 4.98 4.27 4.00 4.09 3.80 3.45 -
P/RPS 0.40 0.40 0.36 0.33 0.34 0.31 0.29 23.88%
P/EPS 12.24 11.08 12.27 7.11 8.57 6.31 6.36 54.65%
EY 8.17 9.03 8.15 14.07 11.66 15.85 15.73 -35.35%
DY 12.58 18.88 0.00 9.25 8.80 14.21 0.00 -
P/NAPS 1.25 1.28 1.04 0.99 1.07 1.02 0.92 22.64%
Price Multiplier on Announcement Date
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Date 04/11/10 11/08/10 26/05/10 19/02/10 13/11/09 21/08/09 08/05/09 -
Price 4.92 4.95 4.71 4.05 3.93 4.00 3.82 -
P/RPS 0.39 0.40 0.40 0.33 0.32 0.33 0.33 11.76%
P/EPS 12.09 11.01 13.53 7.20 8.24 6.64 7.04 43.35%
EY 8.27 9.08 7.39 13.89 12.14 15.06 14.21 -30.27%
DY 12.74 18.99 0.00 9.14 9.16 13.50 0.00 -
P/NAPS 1.24 1.27 1.15 1.00 1.03 1.07 1.02 13.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment